Hepatitis B Therapeutic Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Therapeutic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Therapeutic Drug Overall Market Size
2.1 Global Hepatitis B Therapeutic Drug Market Size: 2021 VS 2028
2.2 Global Hepatitis B Therapeutic Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Therapeutic Drug Players in Global Market
3.2 Top Global Hepatitis B Therapeutic Drug Companies Ranked by Revenue
3.3 Global Hepatitis B Therapeutic Drug Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Therapeutic Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis B Therapeutic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Therapeutic Drug Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Therapeutic Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Therapeutic Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatitis B Therapeutic Drug Market Size Markets, 2021 & 2028
4.1.2 Entecavir
4.1.3 Tenofovir
4.1.4 Lamivudine
4.1.5 Adefovir
4.1.6 Telbivudine
4.1.7 Others
4.2 By Type - Global Hepatitis B Therapeutic Drug Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Therapeutic Drug Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis B Therapeutic Drug Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Therapeutic Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies & Drug Stores
5.1.4 Others
5.2 By Application - Global Hepatitis B Therapeutic Drug Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Therapeutic Drug Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis B Therapeutic Drug Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis B Therapeutic Drug Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis B Therapeutic Drug Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Therapeutic Drug Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis B Therapeutic Drug Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatitis B Therapeutic Drug Revenue, 2017-2028
6.3.2 US Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.3.3 Canada Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.3.4 Mexico Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Therapeutic Drug Revenue, 2017-2028
6.4.2 Germany Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4.3 France Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4.4 U.K. Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4.5 Italy Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4.6 Russia Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4.7 Nordic Countries Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.4.8 Benelux Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Therapeutic Drug Revenue, 2017-2028
6.5.2 China Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.5.3 Japan Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.5.4 South Korea Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.5.5 Southeast Asia Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.5.6 India Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatitis B Therapeutic Drug Revenue, 2017-2028
6.6.2 Brazil Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.6.3 Argentina Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Therapeutic Drug Revenue, 2017-2028
6.7.2 Turkey Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.7.3 Israel Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatitis B Therapeutic Drug Market Size, 2017-2028
6.7.5 UAE Hepatitis B Therapeutic Drug Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Hepatitis B Therapeutic Drug Major Product Offerings
7.1.4 GlaxoSmithKline Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Hepatitis B Therapeutic Drug Major Product Offerings
7.2.4 Bristol-Myers Squibb Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Corporate Summary
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma Hepatitis B Therapeutic Drug Major Product Offerings
7.3.4 Mitsubishi Tanabe Pharma Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.3.5 Mitsubishi Tanabe Pharma Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Hepatitis B Therapeutic Drug Major Product Offerings
7.4.4 Johnson & Johnson Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Hepatitis B Therapeutic Drug Major Product Offerings
7.5.4 Roche Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences Hepatitis B Therapeutic Drug Major Product Offerings
7.6.4 Gilead Sciences Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.6.5 Gilead Sciences Key News
7.7 Merck & Co. Inc.
7.7.1 Merck & Co. Inc. Corporate Summary
7.7.2 Merck & Co. Inc. Business Overview
7.7.3 Merck & Co. Inc. Hepatitis B Therapeutic Drug Major Product Offerings
7.7.4 Merck & Co. Inc. Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.7.5 Merck & Co. Inc. Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Hepatitis B Therapeutic Drug Major Product Offerings
7.8.4 Novartis Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.8.5 Novartis Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Hepatitis B Therapeutic Drug Major Product Offerings
7.9.4 AbbVie Hepatitis B Therapeutic Drug Revenue in Global Market (2017-2022)
7.9.5 AbbVie Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hepatitis B Therapeutic Drug Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Therapeutic Drug Market Drivers in Global Market
Table 3. Hepatitis B Therapeutic Drug Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Therapeutic Drug in Global Market
Table 5. Top Hepatitis B Therapeutic Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis B Therapeutic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis B Therapeutic Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis B Therapeutic Drug Product Type
Table 9. List of Global Tier 1 Hepatitis B Therapeutic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Therapeutic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis B Therapeutic Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis B Therapeutic Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis B Therapeutic Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis B Therapeutic Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis B Therapeutic Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis B Therapeutic Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Hepatitis B Therapeutic Drug Product Offerings
Table 32. GlaxoSmithKline Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Hepatitis B Therapeutic Drug Product Offerings
Table 35. Bristol-Myers Squibb Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 36. Mitsubishi Tanabe Pharma Corporate Summary
Table 37. Mitsubishi Tanabe Pharma Hepatitis B Therapeutic Drug Product Offerings
Table 38. Mitsubishi Tanabe Pharma Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Hepatitis B Therapeutic Drug Product Offerings
Table 41. Johnson & Johnson Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Hepatitis B Therapeutic Drug Product Offerings
Table 44. Roche Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Corporate Summary
Table 46. Gilead Sciences Hepatitis B Therapeutic Drug Product Offerings
Table 47. Gilead Sciences Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Co. Inc. Corporate Summary
Table 49. Merck & Co. Inc. Hepatitis B Therapeutic Drug Product Offerings
Table 50. Merck & Co. Inc. Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Hepatitis B Therapeutic Drug Product Offerings
Table 53. Novartis Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 54. AbbVie Corporate Summary
Table 55. AbbVie Hepatitis B Therapeutic Drug Product Offerings
Table 56. AbbVie Hepatitis B Therapeutic Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatitis B Therapeutic Drug Segment by Type in 2021
Figure 2. Hepatitis B Therapeutic Drug Segment by Application in 2021
Figure 3. Global Hepatitis B Therapeutic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Therapeutic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis B Therapeutic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Therapeutic Drug Revenue in 2021
Figure 8. By Type - Global Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 12. US Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 24. China Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis B Therapeutic Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis B Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mitsubishi Tanabe Pharma Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Co. Inc. Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AbbVie Hepatitis B Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
